Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mei Chee Tai"'
Autor:
Peh Joo Ho, Alexis J. Khng, Hui Wen Loh, Weang-Kee Ho, Cheng Har Yip, Nur Aishah Mohd-Taib, Veronique Kiak Mien Tan, Benita Kiat-Tee Tan, Su-Ming Tan, Ern Yu Tan, Swee Ho Lim, Suniza Jamaris, Yirong Sim, Fuh Yong Wong, Joanne Ngeow, Elaine Hsuen Lim, Mei Chee Tai, Eldarina Azfar Wijaya, Soo Chin Lee, Ching Wan Chan, Shaik Ahmad Buhari, Patrick M. Y. Chan, Juliana J. C. Chen, Jaime Chin Mui Seah, Wai Peng Lee, Chi Wei Mok, Geok Hoon Lim, Evan Woo, Sung-Won Kim, Jong Won Lee, Min Hyuk Lee, Sue K. Park, Alison M. Dunning, Douglas F. Easton, Marjanka K. Schmidt, Soo-Hwang Teo, Jingmei Li, Mikael Hartman
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background Mutations in certain genes are known to increase breast cancer risk. We study the relevance of rare protein-truncating variants (PTVs) that may result in loss-of-function in breast cancer susceptibility genes on tumor characterist
Externí odkaz:
https://doaj.org/article/324c3e5f19e348da8ee1b7ac569530b9
Autor:
Weang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, Xin Yang, Joanna M.C. Lim, Nur Diana Binte Ishak, Peh Joo Ho, Eldarina A. Wijaya, Patsy Pei-Sze Ng, Craig Luccarini, Jamie Allen, Mei-Chee Tai, Jianbang Chiang, Zewen Zhang, Mee-Hoong See, Meow-Keong Thong, Yin-Ling Woo, Alison M. Dunning, Mikael Hartman, Cheng-Har Yip, Nur Aishah Mohd Taib, Douglas F. Easton, Jingmei Li, Joanne Ngeow, Antonis C. Antoniou, Soo-Hwang Teo
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 44, Iss , Pp 101017- (2024)
Summary: Background: Clinical management of Asian BRCA1 and BRCA2 pathogenic variants (PV) carriers remains challenging due to imprecise age-specific breast (BC) and ovarian cancer (OC) risks estimates. We aimed to refine these estimates using six mu
Externí odkaz:
https://doaj.org/article/98fce87ebcdf49c88046d79e3ec0f863
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Supplementary Table #1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867fd9cc4ee7be096e0b5f05339f6df1
https://doi.org/10.1158/1940-6207.22533355.v1
https://doi.org/10.1158/1940-6207.22533355.v1
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Early detection of pancreatic ductal adenocarcinoma (PDAC) is key to improving patient outcomes; however, PDAC is usually diagnosed late. Therefore, blood-based minimally invasive biomarker assays for limited volume clinical samples are urgently need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::421c59b3ca6b058d9ed07898352f8e55
https://doi.org/10.1158/1940-6207.c.6547039.v1
https://doi.org/10.1158/1940-6207.c.6547039.v1
Autor:
Subrata Sen, Ann M. Killary, Randall E. Brand, Anirban Maitra, Cristian Coarfa, Kimberly S. Kirkwood, Pamela L. Paris, Mark W. Hurd, Christine DeCapite, Gary Longton, Ying Huang, Kimal Rajapakshe, Mei Chee Tai, Suyu Liu, Rachel L. Dittmar
Supplemental Figure #1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104b7760e3f4a72868cffea51315ea59
https://doi.org/10.1158/1940-6207.22533361.v1
https://doi.org/10.1158/1940-6207.22533361.v1
Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer
Autor:
Boon Hong Ang, Weang Kee Ho, Eldarina Wijaya, Pui Yoke Kwan, Pei Sze Ng, Sook Yee Yoon, Siti Norhidayu Hasan, Joanna M.C. Lim, Tiara Hassan, Mei-Chee Tai, Jamie Allen, Andrew Lee, Nur Aishah Mohd Taib, Cheng Har Yip, Mikael Hartman, Swee Ho Lim, Ern Yu Tan, Benita K.T. Tan, Su-Ming Tan, Veronique K.M. Tan, Peh Joo Ho, Alexis J. Khng, Alison M. Dunning, Jingmei Li, Douglas F. Easton, Antonis C. Antoniou, Soo Hwang Teo
Publikováno v:
Journal of Clinical Oncology. 40:1542-1551
PURPOSE With the development of poly (ADP-ribose) polymerase inhibitors for treatment of patients with cancer with an altered BRCA1 or BRCA2 gene, there is an urgent need to ensure that there are appropriate strategies for identifying mutation carrie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1830af820964f59029821bd637f61735
https://doi.org/10.1200/jco.21.01647
https://doi.org/10.1200/jco.21.01647
Autor:
Weang-Kee Ho, Mei-Chee Tai, Joe Dennis, Xiang Shu, Jingmei Li, Peh Joo Ho, Iona Y. Millwood, Kuang Lin, Yon-Ho Jee, Su-Hyun Lee, Nasim Mavaddat, Manjeet K. Bolla, Qin Wang, Kyriaki Michailidou, Jirong Long, Eldarina Azfar Wijaya, Tiara Hassan, Kartini Rahmat, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, Su Ming Tan, Ern Yu Tan, Swee Ho Lim, Yu-Tang Gao, Ying Zheng, Daehee Kang, Ji-Yeob Choi, Wonshik Han, Han-Byoel Lee, Michiki Kubo, Yukinori Okada, Shinichi Namba, Sue K. Park, Sung-Won Kim, Chen-Yang Shen, Pei-Ei Wu, Boyoung Park, Kenneth R. Muir, Artitaya Lophatananon, Anna H. Wu, Chiu-Chen Tseng, Keitaro Matsuo, Hidemi Ito, Ava Kwong, Tsun L. Chan, Esther M. John, Allison W. Kurian, Motoki Iwasaki, Taiki Yamaji, Sun-Seog Kweon, Kristan J. Aronson, Rachel A. Murphy, Woon-Puay Koh, Chiea-Chuen Khor, Jian-Min Yuan, Rajkumar Dorajoo, Robin G. Walters, Zhengming Chen, Liming Li, Jun Lv, Keum-Ji Jung, Peter Kraft, Paul D.B. Pharoah, Alison M. Dunning, Jacques Simard, Xiao-Ou Shu, Cheng-Har Yip, Nur Aishah Mohd Taib, Antonis C. Antoniou, Wei Zheng, Mikael Hartman, Douglas F. Easton, Soo-Hwang Teo
Publikováno v:
Genetics in Medicine. 24:586-600
Purpose Non-European populations are under-represented in genetics studies, hindering clinical implementation of breast cancer polygenic risk scores (PRSs). We aimed to develop PRSs using the largest available studies of Asian ancestry and to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac076d8c94f01891867da9bb7b3c493d
https://doi.org/10.1016/j.gim.2021.11.008
https://doi.org/10.1016/j.gim.2021.11.008
Autor:
Ichidai Tanaka, Gargy Parhy, Jaime Rodriguez-Canales, Veera Baladandayuthapani, Francesco C. Stingo, Toyofumi F. Chen-Yoshikawa, Rekha Jain, Seiichi Kato, Jennifer B. Dennison, Kim Anh Do, Yasushi Yatabe, Taisuke Kajino, Kohei Yokoi, Masahiro Nakatochi, Edwin R. Parra, Koji Kawaguchi, Mei Chee Tai, Clemente Aguilar-Bonavides, Ignacio I. Wistuba, Hiroyuki Katayama, Nese Unver, Muge Celiktas, Delphine Dayde, Barbara Mino, Waki Hosoda, Edwin J. Ostrin, Dilsher Dhillon, Johannes F. Fahrmann, Philip L. Lorenzi, Samir M. Hanash, Junya Fujimoto, Carmen Behrens, Yoshiko Murakami, Takayuki Fukui, Satyendra C. Tripathi, Tetsunari Hase, Yoshinori Hasegawa, Julian P. Casabar, Hong Wang, Adi F. Gazdar, Haruki Mori, Ayumu Taguchi, Luisa M. Solis
Publikováno v:
J Natl Cancer Inst
Background Approximately 20% of lung adenocarcinoma (LUAD) is negative for the lineage-specific oncogene Thyroid transcription factor 1 (TTF-1) and exhibits worse clinical outcome with a low frequency of actionable genomic alterations. To identify mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad981770cefe64c8aca4314e255a5cc6
https://doi.org/10.1093/jnci/djab183
https://doi.org/10.1093/jnci/djab183
Autor:
Ehsan Irajizad, Johannes F. Fahrmann, James P. Long, Jody Vykoukal, Makoto Kobayashi, Michela Capello, Chuan-Yih Yu, Yining Cai, Fu Chung Hsiao, Nikul Patel, Soyoung Park, Qian Peng, Jennifer B. Dennison, Taketo Kato, Mei Chee Tai, Ayumu Taguchi, Humam Kadara, Ignacio I. Wistuba, Hiroyuki Katayama, Kim-Anh Do, Samir M. Hanash, Edwin J. Ostrin
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 16; Pages: 8933
There is substantial interest in mining neoantigens for cancer applications. Non-canonical proteins resulting from frameshift mutations have been identified as neoantigens in cancer. We investigated the landscape of non-canonical proteins in non-smal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731a65828b58666e78e0d4966c788234
https://pubmed.ncbi.nlm.nih.gov/36012199
https://pubmed.ncbi.nlm.nih.gov/36012199
Autor:
Mei-Chee Tai, Leonidas E. Bantis, Gargy Parhy, Taketo Kato, Ichidai Tanaka, Chi-Wan Chow, Junya Fujimoto, Carmen Behrens, Tetsunari Hase, Koji Kawaguchi, Johannes F. Fahrmann, Edwin Ostrin, Kohei Yokoi, Toyofumi F. Chen-Yoshikawa, Yoshinori Hasegawa, Samir M. Hanash, Ignacio I. Wistuba, Ayumu Taguchi
Publikováno v:
Cancer Research. 83:3744-3744
Background: Early-stage lung adenocarcinoma (LUAD) patients have substantial risk for recurrence and disease-related death. Cisplatin-based adjuvant chemotherapy remains the standard for care of LUAD patients who have undergone surgical resection wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::930c32c034c5cb1c2ad1d64f1d5b341c
https://doi.org/10.1158/1538-7445.am2023-3744
https://doi.org/10.1158/1538-7445.am2023-3744